Published in J Gastrointest Surg on December 05, 2007
Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol (2012) 1.64
Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis. J Gastroenterol (2011) 1.26
Primary anorectal melanoma. Case Rep Oncol (2014) 1.13
Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res (2011) 1.06
Osteosarcoma: improvement in survival limited to high-grade patients only. J Cancer Res Clin Oncol (2010) 1.03
Primary colonic melanoma presenting as ileocecal intussusception: case report and literature review. World J Gastroenterol (2014) 0.95
Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States. Ann Thorac Surg (2011) 0.87
Primary malignant melanoma of the stomach: report of a case. Surg Today (2011) 0.86
Primary gastric malignant melanoma: challenge in preoperative diagnosis. Int J Clin Exp Pathol (2014) 0.85
Primary malignant melanoma of the esophagus: A case report and review of the literature. Oncol Lett (2015) 0.83
Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database. Clin Orthop Relat Res (2009) 0.83
Mucosal melanomas in the elderly: challenging cases and review of the literature. Clin Interv Aging (2014) 0.82
Primary malignant melanoma of the oesophagus: two case reports. J Surg Case Rep (2014) 0.82
Will patients benefit from regionalization of gynecologic cancer care? PLoS One (2009) 0.82
Primary amelanotic malignant melanoma of the small intestine diagnosed by esophagogastroduodenoscopy before surgical resection. Clin J Gastroenterol (2013) 0.81
Primary malignant achromic melanoma of the lung. Thorac Cancer (2014) 0.78
Primary malignant melanoma of the esophagus. Case Rep Gastroenterol (2013) 0.75
Malignant melanoma of the ileo-anal pouch anastomosis after restorative proctocolectomy for ulcerative colitis: report of a case. Eur J Med Res (2013) 0.75
Primary gastric malignant melanoma mimicking adenocarcinoma. J Gastric Cancer (2014) 0.75
Primary advanced esophago-gastric melanoma: A rare case. World J Gastroenterol (2016) 0.75
Primary Malignant Melanoma of the Esophagus With Unusual Endoscopic Findings: A Case Report and Literature Review. Medicine (Baltimore) (2016) 0.75
Primary malignant melanoma of the gallbladder: an outstandingly rare tumor. Clin Exp Med (2015) 0.75
Induction of cachexia in mice by systemically administered myostatin. Science (2002) 4.39
The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database. Cancer (2012) 3.12
Cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery. Surgery (2008) 2.81
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem (2003) 2.67
Inflammatory myofibroblastic tumors. J Surg Oncol (2006) 2.56
Renal carcinoma with supradiaphragmatic tumor thrombus: avoiding sternotomy and cardiopulmonary bypass. Ann Thorac Surg (2010) 2.51
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes (2003) 2.40
Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol (2006) 2.08
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg (2006) 1.90
Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res (2007) 1.82
Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am (2009) 1.71
Lethal injection for execution: chemical asphyxiation? PLoS Med (2007) 1.63
Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol (2003) 1.62
STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One (2011) 1.61
Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res (2009) 1.61
Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol (2008) 1.60
African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer (2008) 1.57
Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol (2012) 1.57
Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer (2009) 1.56
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab (2012) 1.56
Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol (2007) 1.55
The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer. Surg Endosc (2011) 1.52
Defining treatment and outcomes of hepaticojejunostomy failure following pancreaticoduodenectomy. J Gastrointest Surg (2013) 1.51
Does surgery or radiation therapy impact survival for patients with extrapulmonary small cell cancers? J Surg Oncol (2011) 1.50
Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients. Ann Surg (2008) 1.50
Venous thromboembolism after trauma: a never event?*. Crit Care Med (2012) 1.49
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology (2006) 1.49
Trauma surgeon mortality rates correlate with surgeon time at institution. J Am Coll Surg (2009) 1.49
Does hemopericardium after chest trauma mandate sternotomy? J Trauma Acute Care Surg (2012) 1.48
Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg (2007) 1.48
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun (2009) 1.45
Flexi-seal tube use for enteric fistula control in abdominal wall reconstruction. J Plast Reconstr Aesthet Surg (2010) 1.44
Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus? Ann Surg Oncol (2009) 1.44
Breast cancer in limited-resource countries: early detection and access to care. Breast J (2006) 1.43
Primary lymphoma of bone in adult patients. Cancer (2010) 1.41
Pediatric intestinal foregut and small bowel solid tumors: a review of 105 cases. J Surg Res (2009) 1.40
The Drivers of Academic Success in Cleft and Craniofacial Centers: A 10-Year Analysis of over 2000 Publications. Plast Reconstr Surg (2017) 1.40
Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma. Arch Surg (2010) 1.39
Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer (2009) 1.38
Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock (2005) 1.31
Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer (2010) 1.25
Surgical management of primary breast sarcoma. Am Surg (2002) 1.24
Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma. Liver Int (2005) 1.23
Intestinal and multivisceral transplantation in children. Ann Surg (2006) 1.22
Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients. J Pediatr Surg (2009) 1.21
Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology (2007) 1.20
Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology (2003) 1.19
Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma. Cancer Lett (2006) 1.19
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg (2011) 1.19
Notch activation induces endothelial cell senescence and pro-inflammatory response: implication of Notch signaling in atherosclerosis. Atherosclerosis (2012) 1.16
Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut (2008) 1.16
Detecting blunt pancreatic injuries. J Gastrointest Surg (2002) 1.16
Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. Eur Urol (2006) 1.15
Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor. Cardiovasc Res (2006) 1.15
Molecular pathogenesis of hepatocellular carcinoma. J Surg Res (2006) 1.15
Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005). J Surg Res (2009) 1.14
Rhabdomyosarcoma in children: a SEER population based study. J Surg Res (2011) 1.13
Angiosarcomas of the breast: a review of 70 cases. Am J Clin Oncol (2007) 1.11
Results of 23,810 cases of ductal carcinoma-in-situ. Ann Surg Oncol (2007) 1.10
Malignant abdominal mesothelioma: defining the role of surgery. J Surg Oncol (2009) 1.09
The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Ann Surg Oncol (2009) 1.09
Male breast cancer: is the incidence increasing? Ann Surg Oncol (2004) 1.08
Body surface area prediction in normal, hypermuscular, and obese mice. J Surg Res (2008) 1.07